Zacks: Analysts Expect Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) to Post $0.22 Earnings Per Share

Wall Street brokerages predict that Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRXGet Rating) will post earnings per share (EPS) of $0.22 for the current fiscal quarter, Zacks Investment Research reports. Three analysts have provided estimates for Allscripts Healthcare Solutions’ earnings, with the lowest EPS estimate coming in at $0.21 and the highest estimate coming in at $0.24. Allscripts Healthcare Solutions reported earnings per share of $0.19 in the same quarter last year, which suggests a positive year over year growth rate of 15.8%. The company is expected to issue its next quarterly earnings results after the market closes on Monday, January 1st.

On average, analysts expect that Allscripts Healthcare Solutions will report full year earnings of $1.01 per share for the current year, with EPS estimates ranging from $0.91 to $1.12. For the next financial year, analysts anticipate that the firm will post earnings of $1.09 per share, with EPS estimates ranging from $1.00 to $1.22. Zacks Investment Research’s earnings per share calculations are an average based on a survey of research analysts that that provide coverage for Allscripts Healthcare Solutions.

Allscripts Healthcare Solutions (NASDAQ:MDRXGet Rating) last issued its quarterly earnings data on Thursday, February 24th. The software maker reported $0.72 EPS for the quarter, topping the Zacks’ consensus estimate of $0.25 by $0.47. The company had revenue of $391.70 million for the quarter, compared to analysts’ expectations of $390.63 million. Allscripts Healthcare Solutions had a return on equity of 10.91% and a net margin of 8.94%. The firm’s quarterly revenue was up 1.4% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.24 earnings per share.

MDRX has been the topic of a number of recent research reports. Zacks Investment Research cut Allscripts Healthcare Solutions from a “buy” rating to a “hold” rating and set a $23.00 price objective on the stock. in a research note on Tuesday, March 29th. StockNews.com upgraded Allscripts Healthcare Solutions from a “hold” rating to a “buy” rating in a research note on Friday, April 8th. Deutsche Bank Aktiengesellschaft upgraded Allscripts Healthcare Solutions from a “hold” rating to a “buy” rating and boosted their price target for the stock from $20.00 to $26.00 in a research note on Friday, March 4th. SVB Leerink boosted their price target on Allscripts Healthcare Solutions from $22.00 to $24.00 and gave the stock an “outperform” rating in a research note on Thursday, March 3rd. Finally, TheStreet upgraded Allscripts Healthcare Solutions from a “c+” rating to a “b” rating in a research note on Friday, February 25th. One analyst has rated the stock with a sell rating, three have assigned a hold rating and five have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $22.50.

In other Allscripts Healthcare Solutions news, CFO Richard J. Poulton sold 10,000 shares of the company’s stock in a transaction that occurred on Tuesday, February 15th. The stock was sold at an average price of $20.83, for a total transaction of $208,300.00. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CEO Paul Black sold 60,000 shares of the company’s stock in a transaction that occurred on Thursday, March 10th. The shares were sold at an average price of $21.87, for a total value of $1,312,200.00. The disclosure for this sale can be found here. Corporate insiders own 1.91% of the company’s stock.

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Benjamin F. Edwards & Company Inc. bought a new position in Allscripts Healthcare Solutions during the 3rd quarter worth $31,000. Maverick Capital Ltd. acquired a new position in shares of Allscripts Healthcare Solutions during the third quarter valued at $55,000. CIBC Asset Management Inc acquired a new position in shares of Allscripts Healthcare Solutions during the fourth quarter valued at $200,000. Janus Henderson Group PLC acquired a new position in shares of Allscripts Healthcare Solutions during the third quarter valued at $213,000. Finally, Man Group plc acquired a new position in shares of Allscripts Healthcare Solutions during the third quarter valued at $228,000. 96.40% of the stock is currently owned by institutional investors and hedge funds.

Shares of MDRX opened at $21.65 on Wednesday. The stock’s 50-day moving average is $21.62 and its two-hundred day moving average is $18.66. The stock has a market cap of $2.65 billion, a PE ratio of 21.44, a P/E/G ratio of 1.81 and a beta of 0.98. Allscripts Healthcare Solutions has a 12 month low of $13.05 and a 12 month high of $23.25. The company has a debt-to-equity ratio of 0.25, a current ratio of 1.39 and a quick ratio of 1.39.

About Allscripts Healthcare Solutions (Get Rating)

Allscripts Healthcare Solutions, Inc, together with its subsidiaries, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.

Further Reading

Get a free copy of the Zacks research report on Allscripts Healthcare Solutions (MDRX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Allscripts Healthcare Solutions (NASDAQ:MDRX)

Receive News & Ratings for Allscripts Healthcare Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions and related companies with MarketBeat.com's FREE daily email newsletter.